DK193887D0 - Fysiologisk aktivt peptid - Google Patents

Fysiologisk aktivt peptid

Info

Publication number
DK193887D0
DK193887D0 DK193887A DK193887A DK193887D0 DK 193887 D0 DK193887 D0 DK 193887D0 DK 193887 A DK193887 A DK 193887A DK 193887 A DK193887 A DK 193887A DK 193887 D0 DK193887 D0 DK 193887D0
Authority
DK
Denmark
Prior art keywords
lys
leu
arg
peptid
asn
Prior art date
Application number
DK193887A
Other languages
English (en)
Other versions
DK193887A (da
Inventor
Osamu Ito
Shinro Tachibana
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK193887D0 publication Critical patent/DK193887D0/da
Publication of DK193887A publication Critical patent/DK193887A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK193887A 1986-04-17 1987-04-14 Peptid med bronchodilartorisk og hypotensiv aktivitet DK193887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61086987A JPS62246595A (ja) 1986-04-17 1986-04-17 気菅支拡張作用・降圧作用ペプタイド

Publications (2)

Publication Number Publication Date
DK193887D0 true DK193887D0 (da) 1987-04-14
DK193887A DK193887A (da) 1987-10-18

Family

ID=13902213

Family Applications (1)

Application Number Title Priority Date Filing Date
DK193887A DK193887A (da) 1986-04-17 1987-04-14 Peptid med bronchodilartorisk og hypotensiv aktivitet

Country Status (10)

Country Link
US (2) US4757133A (da)
EP (1) EP0241926B1 (da)
JP (1) JPS62246595A (da)
AT (1) ATE84048T1 (da)
CA (1) CA1288894C (da)
DE (1) DE3783257T2 (da)
DK (1) DK193887A (da)
ES (1) ES2052507T3 (da)
GR (1) GR3006718T3 (da)
NO (1) NO871574L (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
SE8702520D0 (sv) * 1987-06-16 1987-06-16 Kabigen Ab Mammal intestine hormone precursor
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
US5141924A (en) * 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
JPH04193896A (ja) * 1989-10-26 1992-07-13 Meiji Seika Kaisha Ltd 活性ペプチド
JPH03181499A (ja) * 1989-12-11 1991-08-07 Akira Kaji 新規ペプチド
DE69101187T2 (de) * 1990-06-26 1994-09-29 Sanwa Kagaku Kenkyusho Co VIP-Analogen und ihre Verwendung.
JPH05238950A (ja) * 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd 易吸収性ｖｉｐ製剤
US5958881A (en) * 1991-04-25 1999-09-28 Korman; Louis Y. Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
US5623050A (en) * 1991-08-22 1997-04-22 Takeda Chemical Industries, Ltd. Stable polypeptides having c-AMP production enhancing activity and the use thereof
US5998368A (en) * 1991-10-31 1999-12-07 Yeda Research And Development Co. Ltd. Derivatives of structurally modified VIP and pharmaceutical compositions containing them
US5681816A (en) * 1992-04-24 1997-10-28 Korman; Louis Y. Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
US5252747A (en) * 1992-09-11 1993-10-12 Abbott Laboratories Chiral quinolone intermediates
ATE253590T1 (de) * 1995-06-09 2003-11-15 Itoham Foods Inc Peptide, bronchodilator und den blutstrom verbesserndes mittel
KR20050067439A (ko) 2002-11-27 2005-07-01 이토햄 가부시키가이샤 펩티드 및 이를 포함하는 의약조성물
US20080214440A1 (en) * 2004-10-08 2008-09-04 Forbes Medi-Tech (Research), Inc. Vasoactive intestinal polypeptide compositions
US7595294B2 (en) * 2004-10-08 2009-09-29 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide pharmaceuticals
US20090170775A1 (en) * 2004-10-08 2009-07-02 Transition Therapeutics, Inc. Vasoactive intestinal polypeptide compositions
US20070293429A1 (en) * 2004-10-08 2007-12-20 Therapei Pharmaceuticals, Inc. Vasoactive Intestinal Polypeptide Compositions
MX2007004116A (es) * 2004-10-08 2007-10-05 Forbes Medi Tech Res Inc Composiciones farmaceuticas de polipeptidos intestinales vasoactivos.
AU2007271274A1 (en) * 2006-07-06 2008-01-10 F. Hoffmann-La Roche Ag Analogs of vasoactive intestinal peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880826A (en) * 1971-09-17 1975-04-29 Sami I Said Vasoactive intestinal peptide
US3862927A (en) * 1973-02-26 1975-01-28 Sami I Said Process for preparation of vasoactive intestinal peptide
US4016258A (en) * 1975-08-05 1977-04-05 Said Sami I Vasoactive intestinal peptide from fowl
US4605641A (en) * 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs

Also Published As

Publication number Publication date
GR3006718T3 (da) 1993-06-30
EP0241926A2 (en) 1987-10-21
ATE84048T1 (de) 1993-01-15
DE3783257T2 (de) 1993-05-13
DE3783257D1 (de) 1993-02-11
CA1288894C (en) 1991-09-10
EP0241926B1 (en) 1992-12-30
EP0241926A3 (en) 1989-03-08
ES2052507T3 (es) 1994-07-16
JPS62246595A (ja) 1987-10-27
US4757133A (en) 1988-07-12
US4822774A (en) 1989-04-18
DK193887A (da) 1987-10-18
NO871574L (no) 1987-10-19
NO871574D0 (no) 1987-04-14

Similar Documents

Publication Publication Date Title
DK193887D0 (da) Fysiologisk aktivt peptid
CA2024651A1 (en) High-absorbable transvaginal preparation containing biologically active polypeptide
CA2191344A1 (en) Synthetic peptide analogs of lung surfactant protein sp-c
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
EP0340333A3 (en) Novel physiologically active polypeptide and pharmaceutical composition
CA2189947A1 (en) Use of von willebrand factor and pharmaceutical formulation
KR960702754A (ko) 생리적으로 활성인 펩티드를 함유하는 질내 투여 제제(vaginal preparation containing physiologically active peptide)
NO177859C (no) Fremgangsmåte til produksjon av angiogen faktor
AU7831887A (en) Pharmaceutical composition of a short, glycine and tyrosine containing peptide
JPS649938A (en) Oral ingestive composition
SE9000793L (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
GB2180746B (en) Compositions for administering biologically active peptides via mucous membranes
EP0154544A3 (en) Des-proline vasopressin antagonists
AU609435B2 (en) Prevention of bovine respiratory disease complex in cattle by administration of interferon
SE9003040D0 (sv) Analogues of cyclolinopeptide a and the use thereof
IL80786A0 (en) Physiologically active composition comprising a mixture of alkenoic acids
JPS6423899A (en) Novel physiologically active polypeptide

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment